|
IL71505A0
(en)
|
1983-04-14 |
1984-07-31 |
Hughes Howard Med Inst |
Phenylalanine hydroxylase cdna clones,their production and their use in the diagnosis of classical phenylketonuria
|
|
IL74761A0
(en)
|
1984-04-13 |
1985-06-30 |
Hughes Howard Med Inst |
Human phenylalanine hydroxylase cdna clones,their production and their use in diagnosing classical phenylketonuria
|
|
US5436146A
(en)
|
1989-09-07 |
1995-07-25 |
The Trustees Of Princeton University |
Helper-free stocks of recombinant adeno-associated virus vectors
|
|
AU7906691A
(en)
|
1990-05-23 |
1991-12-10 |
United States of America, as represented by the Secretary, U.S. Department of Commerce, The |
Adeno-associated virus (aav)-based eucaryotic vectors
|
|
US5173414A
(en)
|
1990-10-30 |
1992-12-22 |
Applied Immune Sciences, Inc. |
Production of recombinant adeno-associated virus vectors
|
|
US5252479A
(en)
|
1991-11-08 |
1993-10-12 |
Research Corporation Technologies, Inc. |
Safe vector for gene therapy
|
|
DE4339922C1
(de)
|
1993-09-03 |
1994-10-06 |
Max Planck Gesellschaft |
Vektor für Leber-Gentherapie
|
|
US6268212B1
(en)
|
1993-10-18 |
2001-07-31 |
Amgen Inc. |
Tissue specific transgene expression
|
|
JPH10501686A
(ja)
|
1994-04-13 |
1998-02-17 |
ザ ロックフェラー ユニヴァーシティ |
神経系の細胞へのｄｎａのａａｖ仲介送達
|
|
WO1996008560A1
(en)
|
1994-09-16 |
1996-03-21 |
The Uab Research Foundation |
Transduction of genes into human hematopoietic stem cells using recombinant adeno-associated viral vectors
|
|
CN1172435A
(zh)
|
1994-09-23 |
1998-02-04 |
综合医院公司 |
使用非哺乳动物dna病毒在哺乳动物细胞中表达外源基因
|
|
US6924128B2
(en)
|
1994-12-06 |
2005-08-02 |
Targeted Genetics Corporation |
Packaging cell lines for generation of high titers of recombinant AAV vectors
|
|
US5650309A
(en)
|
1995-05-16 |
1997-07-22 |
The Regents Of The University Of California |
Viral vectors
|
|
US7001764B2
(en)
|
1995-06-27 |
2006-02-21 |
Cell Genesys, Inc. |
Compositions comprising tissue specific adenoviral vectors
|
|
DE19525900C1
(de)
|
1995-07-15 |
1996-12-12 |
Max Planck Gesellschaft |
Leberspezifischer Adenovirus-Expressionsvektor
|
|
US5622856A
(en)
|
1995-08-03 |
1997-04-22 |
Avigen |
High efficiency helper system for AAV vector production
|
|
US5780447A
(en)
|
1996-06-14 |
1998-07-14 |
St. Jude Children's Research Hospital |
Recombinant adeno-associated viral vectors
|
|
EP0933997A4
(en)
|
1996-09-06 |
2000-08-16 |
Chiron Corp |
METHODS AND COMPOSITIONS FOR LIVER-SPECIFIC ADMINISTRATION OF THERAPEUTIC MOLECULES USING RECOMBINANT AAV VECTORS
|
|
AU4645697A
(en)
|
1996-09-11 |
1998-04-02 |
Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services, The |
Aav4 vector and uses thereof
|
|
AU4266597A
(en)
|
1996-09-11 |
1998-04-14 |
General Hospital Corporation, The |
Use of a non-mammalian dna virus to express an exogenous gene in a mammalian cell
|
|
DE19644500C2
(de)
|
1996-10-25 |
1998-11-05 |
Deutsches Krebsforsch |
AAV-DNA mit Helfervirus-Sequenzen
|
|
FR2755699B1
(fr)
|
1996-11-08 |
1998-12-18 |
Rhone Poulenc Rorer Sa |
Nouvelles constructions et vecteurs pour l'expression ciblee et inductible des genes
|
|
FR2756297B1
(fr)
|
1996-11-22 |
1999-01-08 |
Centre Nat Rech Scient |
Procede de production de virus recombinants
|
|
WO1998024479A1
(en)
|
1996-12-02 |
1998-06-11 |
Cell Genesys, Inc. |
Adeno-associated viral vector-mediated delivery of dna to cells of the liver
|
|
AU5603998A
(en)
|
1996-12-18 |
1998-07-15 |
Targeted Genetics Corporation |
Recombinase-activatable AAV packaging cassettes for use in the production of AV vectors
|
|
WO1998028417A1
(en)
|
1996-12-23 |
1998-07-02 |
Gene-Cell |
Nucleic acid constructs and uses thereof for direct nucleic acid incorporation into cells
|
|
US6153436A
(en)
|
1997-01-10 |
2000-11-28 |
The Board Of Trustees Of The University Of Arkansas |
Method of gene delivery using wildtype adeno associated viral (AAV) vectors with insertions
|
|
WO1998048005A1
(en)
|
1997-04-24 |
1998-10-29 |
University Of Washington |
Targeted gene modification by parvoviral vectors
|
|
US6156303A
(en)
|
1997-06-11 |
2000-12-05 |
University Of Washington |
Adeno-associated virus (AAV) isolates and AAV vectors derived therefrom
|
|
GB9715064D0
(en)
|
1997-07-17 |
1997-09-24 |
Ppl Therapeutics Scotland Ltd |
Protein expression
|
|
WO1999018227A1
(en)
|
1997-10-08 |
1999-04-15 |
Advanced Research And Technology Institute |
Chimeric parvovirus-based recombinant vector system that specifically targets the erythroid lineage
|
|
US6346415B1
(en)
|
1997-10-21 |
2002-02-12 |
Targeted Genetics Corporation |
Transcriptionally-activated AAV inverted terminal repeats (ITRS) for use with recombinant AAV vectors
|
|
US6953690B1
(en)
|
1998-03-20 |
2005-10-11 |
The Trustees Of The University Of Pennsylvania |
Compositions and methods for helper-free production of recombinant adeno-associated viruses
|
|
US6984517B1
(en)
|
1998-05-28 |
2006-01-10 |
The United States Of America As Represented By The Department Of Health And Human Services |
AAV5 vector and uses thereof
|
|
WO1999064569A1
(en)
|
1998-06-10 |
1999-12-16 |
Advanced Research And Technology Institute |
Methods and compositions for generating recombinant adeno-associated virus vectors
|
|
US6759237B1
(en)
|
1998-11-05 |
2004-07-06 |
The Trustees Of The University Of Pennsylvania |
Adeno-associated virus serotype 1 nucleic acid sequences, vectors and host cells containing same
|
|
EP1135468B1
(en)
|
1998-11-10 |
2010-01-06 |
University Of North Carolina At Chapel Hill |
Virus vectors and methods of making and administering the same
|
|
US6919209B1
(en)
|
1998-12-04 |
2005-07-19 |
City Of Hope |
Method of genetically modifying very primitive quiescent human hematopoietic stem cells
|
|
US6200758B1
(en)
|
1999-02-19 |
2001-03-13 |
New York State Office Of Mental Health |
Phenylalanine hydroxylase gene variants, and amino acid and pterin homeostasis, in the definition, detection, treatment and prevention of psychotic, mood and personality disorders
|
|
JP4693244B2
(ja)
|
1999-03-18 |
2011-06-01 |
ザ・トラステイーズ・オブ・ザ・ユニバーシテイ・オブ・ペンシルベニア |
組換えアデノ随伴ウイルスのヘルパー無しの生産のための組成物および方法
|
|
US6610906B1
(en)
|
1999-06-09 |
2003-08-26 |
The Regents Of The University Of Michigan |
Nucleotide sequences for gene regulation and methods of use thereof
|
|
WO2001036620A2
(en)
|
1999-11-16 |
2001-05-25 |
Genzyme Corporation |
Vectors and transgenies with regulatory elements for gene delivery to the liver
|
|
JP2004514407A
(ja)
|
2000-04-28 |
2004-05-20 |
ザ・トラステイーズ・オブ・ザ・ユニバーシテイ・オブ・ペンシルベニア |
異種キャプシド中にシュードタイピングされたａａｖ５キャプシドおよびａａｖ５ベクターを含む組換えａａｖベクター
|
|
US7465583B2
(en)
|
2000-06-01 |
2008-12-16 |
The University Of North Carolina At Chapel Hill |
Duplexed parvovirus vectors
|
|
US7351813B2
(en)
|
2000-06-20 |
2008-04-01 |
The Board Of Trustees Of The Leland Stanford Junior University |
Liver-specific gene expression cassettes, and methods of use
|
|
US6329181B1
(en)
|
2000-08-07 |
2001-12-11 |
Neurologix, Inc. |
Helper functions for recombinant vector production
|
|
US7749492B2
(en)
|
2001-01-05 |
2010-07-06 |
Nationwide Children's Hospital, Inc. |
AAV vectors and methods
|
|
WO2002066611A2
(en)
|
2001-02-16 |
2002-08-29 |
The Board Of Trustees Of The Leland Stanford Junior University |
Minimal plasmid vectors that provide for persistent and high level gene expression and methods for using the same
|
|
DE10120265A1
(de)
|
2001-04-25 |
2002-11-14 |
Deutsches Krebsforsch |
AAV-Helferplasmide zur Helfervirus-freien Verpackung und Pseudotypisierung von AAV-Vektoren
|
|
WO2002092134A1
(en)
|
2001-05-14 |
2002-11-21 |
Cell Genesys, Inc. |
Lentiviral vectors encoding clotting factors for gene therapy
|
|
US8067156B2
(en)
|
2001-05-31 |
2011-11-29 |
The Rockefeller University |
Method for generating replication defective viral vectors that are helper free
|
|
US8241622B2
(en)
|
2001-07-13 |
2012-08-14 |
University Of Iowa Research Foundation |
Adeno-associated virus vectors with intravector heterologous terminal palindromic sequences
|
|
US20030129203A1
(en)
|
2001-08-27 |
2003-07-10 |
Nautilus Biotech S.A. |
Mutant recombinant adeno-associated viruses
|
|
JP2005526001A
(ja)
|
2001-10-04 |
2005-09-02 |
アグイラルーコルドバ，カリオス，エスツアルド |
遺伝子療法用キメラ型ウイルスベクター
|
|
CA2361462A1
(en)
|
2001-11-07 |
2003-05-08 |
Katherine A. High |
Induction of tolerance to a therapeutic polypeptide
|
|
CN103589692B
(zh)
|
2001-11-13 |
2018-07-24 |
宾夕法尼亚大学托管会 |
检测和/或鉴定腺伴随病毒(aav)序列以及分离所鉴定的新型序列的方法
|
|
EP1463805B1
(en)
|
2001-12-17 |
2014-10-22 |
The Trustees of The University of Pennsylvania |
Adeno-associated virus (aav) serotype 9 sequences, vectors containing same, and uses therefor
|
|
DK2359869T3
(en)
|
2001-12-17 |
2019-04-15 |
Univ Pennsylvania |
Sequences of adeno-associated virus (AAV) serotype 8, vectors containing these, and uses thereof
|
|
CA2369985A1
(en)
|
2002-01-18 |
2003-07-18 |
Duke University |
Generation of recombinant adeno-associated viral vectors by a complete adenovirus-mediated approach
|
|
US20030198620A1
(en)
*
|
2002-04-16 |
2003-10-23 |
Keiya Ozawa |
Method of treating amino acid metabolic disorders using recombinant adeno-associated virus virions
|
|
US7235393B2
(en)
|
2002-04-29 |
2007-06-26 |
The Trustees Of The University Of Pennsylvania |
Method for direct rescue and amplification of integrated viruses from cellular DNA of tissues
|
|
WO2003093436A2
(en)
*
|
2002-04-30 |
2003-11-13 |
University Of Florida |
Treatment for phenylketonuria
|
|
AU2003274397A1
(en)
|
2002-06-05 |
2003-12-22 |
University Of Florida |
Production of pseudotyped recombinant aav virions
|
|
US7220577B2
(en)
|
2002-08-28 |
2007-05-22 |
University Of Florida Research Foundation, Inc. |
Modified AAV
|
|
US20070202587A1
(en)
|
2002-09-23 |
2007-08-30 |
Applied Genetic Technologies Corporation |
Recombinant AAV production in mammalian cells
|
|
US7091029B2
(en)
|
2002-09-23 |
2006-08-15 |
Applied Genetics Technologies Corporation |
High titer recombinant AAV production
|
|
PL2657248T3
(pl)
|
2003-06-19 |
2017-09-29 |
Genzyme Corporation |
Wiriony AAV o zmniejszonej immunoreaktywności i ich zastosowanie
|
|
US9441244B2
(en)
|
2003-06-30 |
2016-09-13 |
The Regents Of The University Of California |
Mutant adeno-associated virus virions and methods of use thereof
|
|
EP1668143B1
(en)
|
2003-09-30 |
2013-03-20 |
The Trustees of The University of Pennsylvania |
Adeno-associated virus (aav) clades, sequences, vectors containing same, and uses therefor
|
|
US7482156B2
(en)
|
2003-10-15 |
2009-01-27 |
Cell Genesys, Inc. |
Hepatocellular carcinoma specific promoter and uses thereof
|
|
EP1732383A4
(en)
|
2004-04-06 |
2007-05-02 |
Cedars Sinai Medical Center |
PREVENTION AND TREATMENT OF VASCULAR DISEASES WITH RECOMBINANT ADENO ASSOCIATED VIRUS VECTORS THAT CODE APOLIPOPROTEIN A-I AND APOLIPOPROTEIN A-I MILANO
|
|
WO2006065273A2
(en)
|
2004-05-24 |
2006-06-22 |
The Regents Of The University Of California |
New human parvovirus
|
|
ES2436741T3
(es)
|
2004-09-22 |
2014-01-07 |
St. Jude Children's Research Hospital |
Expresión mejorada de Factor IX en vectores de terapia génica
|
|
TWI293307B
(en)
|
2004-09-30 |
2008-02-11 |
Ind Tech Res Inst |
A liver-specific chimeric regulatory sequence and use thereof
|
|
US8658778B2
(en)
|
2005-03-09 |
2014-02-25 |
Board Of Regents, The University Of Texas System |
hTMC promoter and vectors for the tumor-selective and high-efficient expression of cancer therapeutic genes
|
|
DE23193606T1
(de)
|
2005-04-07 |
2024-02-15 |
The Trustees Of The University Of Pennsylvania |
Verfahren zur erhöhung der funktion eines aav-vektors
|
|
US8283151B2
(en)
|
2005-04-29 |
2012-10-09 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Isolation, cloning and characterization of new adeno-associated virus (AAV) serotypes
|
|
WO2007019646A1
(en)
|
2005-08-19 |
2007-02-22 |
University Of Technology, Sydney |
Liver-directed gene therapy
|
|
PT3272872T
(pt)
|
2005-10-20 |
2020-06-26 |
Uniqure Ip Bv |
Vetores aav melhorados produzidos em células de insetos
|
|
WO2007084773A2
(en)
|
2006-01-20 |
2007-07-26 |
University Of North Carolina At Chapel Hill |
Enhanced production of infectious parvovirus vectors in insect cells
|
|
WO2008016391A2
(en)
|
2006-01-31 |
2008-02-07 |
The Board Of Trustees Of The Leland Stanford Junior University |
Self-complementary parvoviral vectors, and methods for making and using the same
|
|
US7588772B2
(en)
|
2006-03-30 |
2009-09-15 |
Board Of Trustees Of The Leland Stamford Junior University |
AAV capsid library and AAV capsid proteins
|
|
US8298818B2
(en)
|
2006-04-28 |
2012-10-30 |
University Of Florida Research Foundation, Inc. |
Self-complementary adeno-associated virus having a truncated CMV-chicken β-actin promoter
|
|
DK2623605T3
(en)
|
2007-04-09 |
2019-03-25 |
Univ Florida |
RAAV VECTOR COMPOSITIONS WITH TYROSIN MODIFIED CAPSIDE PROTEINS AND PROCEDURES FOR USE THEREOF
|
|
US9725485B2
(en)
|
2012-05-15 |
2017-08-08 |
University Of Florida Research Foundation, Inc. |
AAV vectors with high transduction efficiency and uses thereof for gene therapy
|
|
WO2008150459A1
(en)
|
2007-05-30 |
2008-12-11 |
The Trustees Of The University Of Pennsylvania |
A method for transducing cells with primary cilia
|
|
EP2008656A1
(en)
|
2007-06-28 |
2008-12-31 |
Bergen Teknologioverforing AS |
Compositions for the treatment of hyperphenylalaninemia
|
|
EP2058401A1
(en)
|
2007-10-05 |
2009-05-13 |
Genethon |
Widespread gene delivery to motor neurons using peripheral injection of AAV vectors
|
|
WO2009108274A2
(en)
|
2008-02-26 |
2009-09-03 |
The University Of North Carolina At Chapel Hill |
Methods and compositions for adeno-associated virus (aav) with hi loop mutations
|
|
US9617548B2
(en)
|
2008-04-22 |
2017-04-11 |
Vib Vzw |
Liver-specific nucleic acid regulatory elements and methods and use thereof
|
|
WO2009134681A2
(en)
|
2008-04-30 |
2009-11-05 |
The Trustees Of The University Of Pennsylvania |
Aav7 viral vectors for targeted delivery of rpe cells
|
|
US8632764B2
(en)
|
2008-04-30 |
2014-01-21 |
University Of North Carolina At Chapel Hill |
Directed evolution and in vivo panning of virus vectors
|
|
EP2910637A1
(en)
|
2008-05-20 |
2015-08-26 |
University of Florida Research Foundation, Inc. |
Vectors for delivery of light-sensitive proteins and methods of use
|
|
US9217155B2
(en)
|
2008-05-28 |
2015-12-22 |
University Of Massachusetts |
Isolation of novel AAV'S and uses thereof
|
|
US20100316623A1
(en)
*
|
2009-04-23 |
2010-12-16 |
Andrew Turner |
Phenylalanine hydroxylase fusion protein and methods for treating phenylketonuria
|
|
DK2425000T3
(da)
|
2009-04-30 |
2019-05-13 |
Univ Pennsylvania |
Sammensætninger rettet mod ledende luftvejsceller omfattende konstrukter af adeno-associeret virus
|
|
SI3988660T1
(sl)
|
2009-05-02 |
2025-09-30 |
Genzyme Corporation |
Genska terapija za nevrodegenerativne motnje
|
|
WO2010136549A2
(en)
|
2009-05-28 |
2010-12-02 |
Deutsches Krebsforschungszentrum |
Modified aav capsid polypeptides
|
|
JP5956331B2
(ja)
|
2009-06-16 |
2016-07-27 |
ジェンザイム・コーポレーション |
組換えａａｖベクターの改良された精製方法
|
|
GB0911870D0
(en)
|
2009-07-08 |
2009-08-19 |
Ucl Business Plc |
Optimised coding sequence and promoter
|
|
EP2287323A1
(en)
|
2009-07-31 |
2011-02-23 |
Association Institut de Myologie |
Widespread gene delivery to the retina using systemic administration of AAV vectors
|
|
WO2011038187A1
(en)
|
2009-09-25 |
2011-03-31 |
The Trustees Of The University Of Pennsylvania |
Controlled adeno-associated virus (aav) diversification and libraries prepared therefrom
|
|
US20120244127A1
(en)
|
2009-10-01 |
2012-09-27 |
The Trustees Of The University Of Pennsylvania |
AAV Vectors Expressing SEC10 for Treating Kidney Damage
|
|
US9169494B2
(en)
|
2010-01-12 |
2015-10-27 |
The University Of North Carolina At Chapel Hill |
Restrictive inverted terminal repeats for viral vectors
|
|
EP2529020B1
(en)
|
2010-01-28 |
2018-04-25 |
The Children's Hospital of Philadelphia |
A scalable manufacturing platform for viral vector purification and viral vectors so purified for use in gene therapy
|
|
US9546112B2
(en)
|
2010-03-22 |
2017-01-17 |
Association Institut De Myologie |
Methods of increasing efficiency of vector penetration of target tissue
|
|
WO2011126808A2
(en)
|
2010-03-29 |
2011-10-13 |
The Trustees Of The University Of Pennsylvania |
Pharmacologically induced transgene ablation system
|
|
US9839696B2
(en)
*
|
2010-04-30 |
2017-12-12 |
City Of Hope |
Recombinant adeno-associated vectors for targeted treatment
|
|
US8927514B2
(en)
*
|
2010-04-30 |
2015-01-06 |
City Of Hope |
Recombinant adeno-associated vectors for targeted treatment
|
|
US8628966B2
(en)
|
2010-04-30 |
2014-01-14 |
City Of Hope |
CD34-derived recombinant adeno-associated vectors for stem cell transduction and systemic therapeutic gene transfer
|
|
EP2394667A1
(en)
|
2010-06-10 |
2011-12-14 |
Laboratorios Del Dr. Esteve, S.A. |
Vectors and sequences for the treatment of diseases
|
|
US20120014932A1
(en)
|
2010-07-14 |
2012-01-19 |
Golden William J |
Methods for treating disorders of amino acid metabolism
|
|
CA2826273C
(en)
|
2011-02-10 |
2021-11-02 |
The University Of North Carolina At Chapel Hill |
Viral vectors with modified transduction profiles and methods of making and using the same
|
|
ES2685611T3
(es)
|
2011-02-14 |
2018-10-10 |
The Children's Hospital Of Philadelphia |
Vector VAA8 mejorado con una actividad funcional aumentada y métodos de utilización del mismo
|
|
CN103502458B
(zh)
*
|
2011-02-17 |
2016-11-16 |
宾夕法尼亚大学托管会 |
用于改变组织特异性和改善aav9-介导的基因转移的组合物和方法
|
|
GB201103062D0
(en)
|
2011-02-22 |
2011-04-06 |
Isis Innovation |
Method
|
|
EP2681327B1
(en)
|
2011-03-04 |
2018-11-21 |
Intrexon Corporation |
Vectors conditionally expressing protein
|
|
DK3693025T3
(da)
|
2011-04-22 |
2022-01-10 |
Univ California |
Adenoassocierede virus-virioner med variant capsid og fremgangsmåder til anvendelse heraf
|
|
EP3795581A3
(en)
|
2011-08-24 |
2021-06-09 |
The Board of Trustees of the Leland Stanford Junior University |
New avv capsid proteins for nucleic acid transfer
|
|
US9222105B2
(en)
|
2011-10-27 |
2015-12-29 |
Sangamo Biosciences, Inc. |
Methods and compositions for modification of the HPRT locus
|
|
EP2782596A4
(en)
|
2011-11-22 |
2015-07-29 |
Philadelphia Children Hospital |
VIRUS VECTORS FOR HIGHLY EFFICIENT TRANSGENIC ADMINISTRATION
|
|
US20140359799A1
(en)
|
2011-12-23 |
2014-12-04 |
Case Western Reserve University |
Targeted gene modification using hybrid recombinant adeno-associated virus
|
|
BR112014020325A2
(pt)
|
2012-02-17 |
2017-08-08 |
Childrens Hospital Philadelphia |
composições de vetor do aav e métodos para a transferência de gene para as células, órgãos e tecidos
|
|
JP6342886B2
(ja)
|
2012-04-18 |
2018-06-13 |
ザ・チルドレンズ・ホスピタル・オブ・フィラデルフィアＴｈｅ Ｃｈｉｌｄｒｅｎ’Ｓ Ｈｏｓｐｉｔａｌ Ｏｆ Ｐｈｉｌａｄｅｌｐｈｉａ |
Ａａｖカプシドバリアントを使用した高効率な遺伝子導入のための組成物及び方法
|
|
US9604226B2
(en)
*
|
2012-05-01 |
2017-03-28 |
Innovative Combustion Technologies, Inc. |
Pulverizer mill protection system
|
|
TWI698240B
(zh)
*
|
2012-05-15 |
2020-07-11 |
澳大利亞商艾佛蘭屈澳洲私營有限公司 |
使用腺相關病毒(aav)sflt-1治療老年性黃斑部退化(amd)
|
|
HK1210214A1
(en)
|
2012-07-06 |
2016-04-15 |
University Of Iowa Research Foundation |
Modified adeno-associated virus vector compositions
|
|
PL2900686T3
(pl)
|
2012-09-28 |
2021-01-25 |
The University Of North Carolina At Chapel Hill |
Wektory aav ukierunkowane na oligodendrocyty
|
|
DK2911687T3
(da)
|
2012-10-26 |
2019-05-13 |
Univ Brussel Vrije |
Vektor til levermålrettet genterapi af hæmofili og fremgangsmåder og anvendelse deraf
|
|
CA2892448A1
(en)
|
2012-12-05 |
2014-06-12 |
Sangamo Biosciences, Inc. |
Methods and compositions for regulation of metabolic disorders
|
|
EP2940131B1
(en)
|
2012-12-25 |
2019-02-20 |
Takara Bio Inc. |
Aav variant
|
|
WO2014109728A1
(en)
|
2013-01-11 |
2014-07-17 |
The Scripps Research Institute |
Methods and compositions for enchancing transduction efficiency of retroviral vectors
|
|
WO2014124282A1
(en)
|
2013-02-08 |
2014-08-14 |
The Trustees Of The University Of Pennsylvania |
Enhanced aav-mediated gene transfer for retinal therapies
|
|
EP2970946A4
(en)
|
2013-03-13 |
2016-09-07 |
Philadelphia Children Hospital |
ADENOASSOZED VIRUS VECTORS AND METHOD FOR USE THEREOF
|
|
US20140271550A1
(en)
|
2013-03-14 |
2014-09-18 |
The Trustees Of The University Of Pennsylvania |
Constructs and Methods for Delivering Molecules via Viral Vectors with Blunted Innate Immune Responses
|
|
JP2016517278A
(ja)
|
2013-03-15 |
2016-06-16 |
ザ・チルドレンズ・ホスピタル・オブ・フィラデルフィアＴｈｅ Ｃｈｉｌｄｒｅｎ’Ｓ Ｈｏｓｐｉｔａｌ Ｏｆ Ｐｈｉｌａｄｅｌｐｈｉａ |
スタッファー／フィラーポリヌクレオチド配列を含むベクターおよびその使用方法
|
|
EP2970966A4
(en)
*
|
2013-03-15 |
2016-10-26 |
Univ North Carolina |
SYNTHETIC ADENOASSOZED VIRUS INVERTED REPEAT SEQUENCES
|
|
BR112015021036A2
(pt)
|
2013-03-15 |
2017-10-10 |
Univ Pennsylvania |
composições e métodos para tratar mps1
|
|
US9700486B2
(en)
*
|
2013-04-24 |
2017-07-11 |
Corning Incorporated |
Delamination resistant pharmaceutical glass containers containing active pharmaceutical ingredients
|
|
KR102298579B1
(ko)
|
2013-05-21 |
2021-09-07 |
유니버시티 오브 플로리다 리서치 파운데이션, 인코포레이티드 |
캡시드-변형된 raav3 벡터 조성물, 및 인간 간암의 유전자 요법에서의 용도
|
|
US11136557B2
(en)
|
2013-05-31 |
2021-10-05 |
The Regents Of The University Of California |
Adeno-associated virus variants and methods of use thereof
|
|
WO2015006743A1
(en)
|
2013-07-12 |
2015-01-15 |
The Children's Hospital Of Philadelphia |
Aav vector and assay for anti-aav (adeno-associated virus) neutralizing antibodies
|
|
NZ716102A
(en)
|
2013-07-22 |
2021-12-24 |
The Children’S Hospital Of Philadelphia |
Variant aav and compositions, methods and uses for gene transfer to cells, organs and tissues
|
|
EP3564379A1
(en)
|
2013-09-13 |
2019-11-06 |
California Institute of Technology |
Selective recovery
|
|
EP3058072B1
(en)
|
2013-10-17 |
2021-05-19 |
Sangamo Therapeutics, Inc. |
Delivery methods and compositions for nuclease-mediated genome engineering
|
|
EP3574923A1
(en)
|
2013-10-22 |
2019-12-04 |
Translate Bio, Inc. |
Mrna therapy for phenylketonuria
|
|
US10612041B2
(en)
|
2014-03-21 |
2020-04-07 |
The Board Of Trustees Of The Leland Stanford Junior University |
Genome editing without nucleases
|
|
WO2015164723A1
(en)
|
2014-04-25 |
2015-10-29 |
The Trustees Of The University Of Pennsylvania |
Methods and compositions for treating metastatic breast cancer and other cancers in the brain
|
|
US10781459B2
(en)
*
|
2014-06-20 |
2020-09-22 |
University Of Florida Research Foundation, Incorporated |
Methods of packaging multiple adeno-associated virus vectors
|
|
WO2016049230A1
(en)
*
|
2014-09-24 |
2016-03-31 |
City Of Hope |
Adeno-associated virus vector variants for high efficiency genome editing and methods thereof
|
|
JP6754361B2
(ja)
|
2014-12-16 |
2020-09-09 |
ボード オブ リージェンツ オブ ザ ユニバーシティ オブ ネブラスカ |
若年型バッテン病のための遺伝子療法
|
|
CN107208105A
(zh)
|
2014-12-17 |
2017-09-26 |
基础应用医学研究基金会 |
用于治疗威尔森病的核酸构建体和基因治疗载体
|
|
US11118238B2
(en)
|
2014-12-17 |
2021-09-14 |
Fundación Para La Investigación Mèdica Aplicada |
Nucleic acid constructs and gene therapy vectors for use in the treatment of Wilson's disease and other conditions
|
|
KR102554850B1
(ko)
|
2015-02-06 |
2023-07-13 |
더 유니버시티 오브 노쓰 캐롤라이나 엣 채플 힐 |
최적화된 인간 응고 인자 viii 유전자 발현 카세트 및 그의 용도
|
|
JP6879486B2
(ja)
|
2015-03-17 |
2021-06-02 |
フリーイェ・ユニヴェルシテイト・ブリュッセルＶｒｉｊｅ Ｕｎｉｖｅｒｓｉｅｉｔ Ｂｒｕｓｓｅｌ |
Ｆｖｉｉｉおよびｆｉｘ用の最適化された肝臓特異的発現系
|
|
CN115094062A
(zh)
|
2015-04-16 |
2022-09-23 |
埃默里大学 |
用于肝脏中蛋白质表达的重组启动子和载体及其用途
|
|
WO2017015154A1
(en)
|
2015-07-17 |
2017-01-26 |
Children's National Medical Center |
Methods and compositions for treating phenyltonuria
|
|
US10143760B2
(en)
|
2015-10-28 |
2018-12-04 |
Sangamo Therapeutics, Inc. |
Liver-specific constructs, factor VIII expression cassettes and methods of use thereof
|
|
WO2017100551A1
(en)
|
2015-12-09 |
2017-06-15 |
Alexion Pharmaceuticals, Inc. |
HETEROLOGOUS UTR SEQUENCES FOR ENHANCED mRNA EXPRESSION
|
|
WO2018046737A1
(en)
|
2016-09-09 |
2018-03-15 |
Fondazione Telethon |
Combined therapy for mucopolysaccharidosis type vi (maroteaux-lamy-syndrome)
|
|
EP3562494A4
(en)
*
|
2016-12-30 |
2020-08-19 |
The Trustees Of The University Of Pennsylvania |
GENE THERAPY FOR THE TREATMENT OF PHENYLKETONURIS
|
|
KR102863181B1
(ko)
|
2016-12-30 |
2025-09-23 |
더 트러스티스 오브 더 유니버시티 오브 펜실베니아 |
윌슨병을 치료하기 위한 유전자 치료
|
|
US11938197B2
(en)
|
2017-01-10 |
2024-03-26 |
The Sydney Children's Hospitals Network (Randwick And Westmead (Incorporating The Royal Alexandra Hospital For Children) |
Polynucleotides and vectors for the expression of transgenes
|
|
WO2019010091A1
(en)
|
2017-07-06 |
2019-01-10 |
The Board Of Trustees Of The Leland Stanford Junior University |
METHODS AND COMPOSITIONS FOR FACILITATING HOMOLOGOUS RECOMBINATION
|
|
WO2019152841A1
(en)
*
|
2018-02-01 |
2019-08-08 |
Homology Medicines, Inc. |
Adeno-associated virus compositions for pah gene transfer and methods of use thereof
|